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INTRODUTION
rostate cancer is one 
of the leading causes 
of disease and mortal-
ity among men and, 
each year, 1.6 million 
men are diagnosed and 366,000 
men die from prostate cancer.(1) It 
???????????? ????????????????????
cancer death around the world. (2) 
Prostate cancer is particularly 
common in developed countries. 
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Abstract
Prostate cancer causes changes, such as erectile dysfunction, with a significant 
impact on the perception of quality of life (QoL). The aim of this study is to identi-
fy changes in perception of QoL related to erectile dysfunction over time.
A descriptive, analytical and longitudinal study was conducted with the partic-
ipation of oncological patients from the ambulatory urology department of an 
oncology hospital unit of the North of Portugal. The sample, obtained through 
convenience non-probabilistic sampling between October 2015 and July 2016, 
included 60 patients. The instrument used for data collection was IIEF-5 (Interna-
tional Index of Erectile Function-5) that evaluates the severity degree of erectile 
dysfunction (ED).
Sexual function did not present clinical or statistical differences along the studied 
period. Cultural issues related to privacy preservation may justify our sexual func-
tion scores. 
Early identification of QoL changes may guide nurses to patient-centered care.
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SEXUAL DYSFUNCTION 
AND QUALITY OF LIFE  
IN PROSTATE CANCER
P
It is amongst 12% of all cancers in 
Europe. In developed countries, it 
accounts for 1 in 10 deaths in men 
with cancer.(3) 
It is more common in men over 50 
years of age, accounting for about 
3.5% of all global deaths and 10% 
of all deaths from male cancers. 
(3) (4) Both incidence and mortality 




multifactorial impacts of genetic 
variation, diet, lifestyle and envi-
ronmental factors, access to health 
care and availability (5)  This dis-
order is predominantly a disease 
of older men with 70 years of age 
or older. According the National 
Cancer Institute, (6) the mean age 
at diagnosis is 68 years, where 
71.2% of deaths due to prostate 
cancer occur in men older than or 
equal to 75 years. With the growing 
aging population and rising life 
expectancy in developed countries, 
prostate cancer cases are project-
ed to increase dramatically in the 
future. (6) 
The diagnosis and treatment of 
prostate cancer can lead to signif-
icant changes in the life of men, 
especially the level of sexual ac-
tivity and, consequently, to change 
their quality of life (QoL). (7)
Sexuality is an important part of 
normal human functioning, but 
this is an aspect of care that has 
been largely ignored by health pro-
fessionals and caregivers. (8) 
A 2018 study showed that sexual 
dysfunction affects 26% of men 
after prostatectomy, the period 
required for recovery from erectile 
function after surgery varies be-
tween 6 and 48 months. (9) 
Research studies(9)(10) on health-re-
lated quality of life (HRQoL) report 
that one year after prostatectomy, 
men are more concerned with 
sexual function than with the 
possibility of recurrence of cancer. 
Persistence of side effects after 
prostatectomy may result in signif-
icant changes in patients’ quality 
of life.
This way health professionals have 
a responsibility to ensure that can-
cer survivors and their partners 
experience a better quality of life 
during the years of survival.
???????????????????????????????????
may guide nurses to patient-cen-
tered care.
AIM
The present study aims to identify 
the perception of QoL related to 
erectile dysfunction over time.
METHODS
This is a descriptive, analytical 
and a longitudinal study, with the 
participation of cancer patients 
from an oncology hospital unit. The 
non-probability sample consisted of 
60 patients who visited the doctor’s 
????????????????????????????????
2016. The inclusion criteria included 
patients aged over 18 years and pa-
tients with prostate cancer. Patients 
were excluded if they could not 
read or write in Portuguese and had 
neurological and cognitive changes 
that prevented them from complet-
ing the questionnaire.
TABLE 1
CHARACTERIZATION (N = 60)
N %
Age
      45 a 54 3 5,0
      55 a 64 17 28,3
      65 a 74 22 36,7
      75 a 84 11 18,3
      85 and more 7 11,7
Literary qualifications
      Without qualifications 12 20,0
      Up to 12 years of schooling 32 53,3
      Higher education Ensino Superior 16 26,7
Profision
      Retired 32 53,3
      Unemployed 1 1,7
      Representatives of the legislature 1 1,7
      Workers in personal protective services 5 8,3
      Plant and machine operators 4 6,7
      Skilled workers in industry, construction 3 5,0
      Farmers and skilled agricultural workers 3 5,0
      Specialists in Intellectual and Scientific Activities 10 16,7
      Middle level technicians and professions 1 1,7
Marital status
      Single 5 8,3
      Married 41 68,3
      Divorced 4 6,7
      Widower 10 16,7
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The IIEF-5 (International Erectile 
Function Index-5) scale that eval-
uates the prevalence of erectile 
dysfunction (ED) was used. The 
possible scores for IIEF5 range from 
1 to 25 (each question has scores 
of 1 - 5). Thus, a zero response to a 
question was considered to be less 
???????????? ???????????????????????
was considered to be more func-
tional. A score above 21 was consid-
ered a normal erectile function and 
values  equal to or below 21 consid-
ered with erectile dysfunction.
According to this scale, ED is clas-
????????????????????????????????????
IIEF-5 values: severe (5-7); moder-
ate (8-11); mild to moderate (12-16); 
(17-21), and without DE (22-25). (11) 
Data was performed in four mo-
ments coincident with the fol-
low-up nursing consultations. In 
order to understand the changes 
in the QoL, and according to the 
moments recommended by the 
institution for patient follow-up, 
we started the data collection 
?????????????????????????????????-
agnosis (M0) and continued one 
month (M1), three months (M3) and 
months (M6) after treatment was 
started.
Data was analyzed using SPSS® 
(Statistical Package for the Social 
Sciences) version 25.0 for Windows. 
All ethical-legal considerations 
were respected. The voluntary na-
ture of the participation is empha-
sized and a declaration of informed 
consent has been signed by each 
participant. This research was 
approved by the board of directors 
of the institution and the Ethics 
????????????????????????????????
RESULTS
The sample consisted of 60 men 
with a mean age of 69.8 years (SD 
= 9.8 years), ranging from a mini-
mum of 51 years to a maximum of 
90 years. The majority are in the 
65-74 age group (36.7%), are mar-
ried (68.3%), have up to 12 years of 
schooling (53.3%) and are in a re-
tirement situation (53.3%). Table 1.
Almost half of the sample under-
went a non-surgical treatment (45%) 
30% to a surgery. Table 2.
Table 3???????????????????????
evolution of IIEF-5 values  in the 4 
evaluation moments. Despite the 
increase in IIEF-5 values, the differ-
??????????????????????????????????-
cant, F repeated measures (3, 177) = 
0.856, p = .465. Table 3 and Figure 1.
It was found that there were no ma-
jor changes in sexual dysfunction 
over time (M = 15.4), however, there 
was a slight change from M0 to M1 
???? ????? ?? ????????????????-
cant decrease in values.
DISCUSSION
In prostate cancer, age is an im-
portant risk factor, since both 
incidence and mortality increase 
??????????????????????????
The mean age of study participants 
is 69.8 years; 36.7% of the partici-
pants are in the age range of 65-74 
years, older than 50 years, corrobo-
rating with the observation that age 
?????????????????????????????????????
sample studied.
Regard sexual dysfunction, as Mat-
thew et al(9) shows, it is a situation 
of high prevalence in modern so-
cieties, partly because of the aging 
population and the increase in the 
number of new cases of cancer 
each year.Erectile dysfunction 
encompasses a variety of phys-
ical aspects with an important 
contribution of psychological and 
behavioral aspects. The presence 
of symptoms in patients with 
prostate cancer can cause chang-
es in QoL, what may be a variable 
strongly associated with erectile 
dysfunction. (12) 
In the sample, 30% of the patients 
underwent surgery, so it would 
??????????????????????????????-
?????????????????????????????????
months after surgery, as indicated 
by Matthew et al. (13) , however, 
and although there were changes 
these are not very relevant, Anoth-
er study by Chien et al. (14) shows 
that there are changes in sexual 
function regardless of the type of 
treatment, with sexual function 
?????????????????????????? ???????
??????? ??????????????????????????
months of the patients undergoing 
surgery, which is in line with our 
results which, although not statis-
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Mínimum Máximum Mean Standard deviation
Moment 0 5 25 15,28 5,19
Moment 1 5 25 14,67 5,41
Moment 3 5 25 16,13 5,21














diagnosis. The lack of statistically 
????????????????????????????????-
od studied may take into account 
privacy preservation issues, as the 
study by Sequeira et al. (3) 
CONCLUSIONS
Sexual dysfunction is one of the 
most prevalent and long-lasting 
consequences of prostate cancer 
treatment. Chien et al. (14)?????????
that, regardless the treatment, the 
sexual function decreases in the 
???????? ??????? ????????????????-
ment with the results obtained in 
the study. Identifying the moments 
where the perception of QoL under-
goes changes allows the nursing 
team a more targeted intervention 
for each patient.
The study has some limitations 
regarding the sample size. With 
a larger sample larger we could, 
probably, have obtained more 
marked responses in this domain. 
???????????????????????????????????
proved to be complex due to the 
dynamics of the institution, which 
led to the loss of patients able to 
participate.
The institution of a nursing fol-
low-up model focused on the 
FIGURE 1
EVOLUTION OF IIEF VALUES
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vulnerabilities of patients with 
prostate cancer shall allow to work 
in an individualized way with each 
patient in order to improve the 
domains more affected and conse-
quently a better quality of life. 
